Healthcare Value Capital as of March 31, 2021
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 21 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 10.8 | $4.8M | 75k | 64.63 | |
| Pfizer (PFE) | 8.1 | $3.6M | 100k | 36.23 | |
| Glaxosmithkline Sponsored Adr | 7.9 | $3.6M | 100k | 35.69 | |
| Clovis Oncology | 7.0 | $3.2M | 450k | 7.02 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 6.2 | $2.8M | 250k | 11.18 | |
| Vyne Therapeutics | 6.1 | $2.7M | 400k | 6.84 | |
| Tyme Technologies | 5.9 | $2.7M | 1.5M | 1.78 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 5.3 | $2.4M | 100k | 23.70 | |
| Proshares Tr Ultrapro Short S Call Option (SPXU) | 5.3 | $2.4M | 100k | 23.68 | |
| Amryt Pharma Sponsored Ads | 4.8 | $2.2M | 156k | 13.93 | |
| Antares Pharma | 4.6 | $2.1M | 500k | 4.11 | |
| Alkermes SHS (ALKS) | 4.2 | $1.9M | 100k | 18.68 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 4.1 | $1.9M | 300k | 6.21 | |
| Bristol Myers Squibb (BMY) | 3.5 | $1.6M | 25k | 63.12 | |
| Merck & Co (MRK) | 3.4 | $1.5M | 20k | 77.10 | |
| Greenlane Hldgs Cl A | 3.0 | $1.3M | 250k | 5.30 | |
| Aurinia Pharmaceuticals (AUPH) | 2.9 | $1.3M | 100k | 12.99 | |
| Astrazeneca Sponsored Adr (AZN) | 2.8 | $1.2M | 25k | 49.72 | |
| Proshares Tr Ii Vix Sh Trm Futrs Call Option | 2.1 | $935k | 100k | 9.35 | |
| Adamas Pharmaceuticals | 1.1 | $480k | 100k | 4.80 | |
| Gamida Cell SHS (GMDA) | 0.9 | $405k | 50k | 8.10 |
